Cargando…
COVID-19 Vaccine Hesitancy Among Patients with Inflammatory Bowel Diseases at a Diverse Safety Net Hospital
BACKGROUND AND AIMS: Patients with inflammatory bowel disease (IBD) and underrepresented minorities (URMs) historically have below average vaccination rates. URMs have increased morbidity and mortality from COVID-19. We surveyed IBD patients to assess COVID vaccination attitudes, particularly among...
Autores principales: | Herman, Howard S., Rosenthaler, Max P., Elhassan, Noon, Weinberg, Janice M., Satyam, Venkata R., Wasan, Sharmeel K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853212/ https://www.ncbi.nlm.nih.gov/pubmed/35175432 http://dx.doi.org/10.1007/s10620-022-07413-y |
Ejemplares similares
-
The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab
por: Harrington, Jill E, et al.
Publicado: (2020) -
COVID-19 Vaccine Hesitancy in Patients with Inflammatory Bowel Disease
por: Clarke, Kofi, et al.
Publicado: (2022) -
Standardizing Endoscopy Training: A Workshop for Endoscopy Educators
por: Huang, Christopher, et al.
Publicado: (2020) -
SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study
por: Cao, Yubin, et al.
Publicado: (2022) -
Patients with inflammatory bowel disease are more hesitant about Coronavirus disease 2019 vaccination
por: Kwon, Hyuk Joon, et al.
Publicado: (2022)